Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors—a smart fighter that destroys cancer cells for days without tiring. USC biomedical engineers have made this concept a reality, ...
Apr 2, 2025
0
50
Researchers at the University of Kentucky analyzed different factors that could explain the high mortality rates of colorectal cancer in Appalachian Kentucky.
Apr 2, 2025
0
0
Obesity is associated with an increased risk of developing breast cancer, and a greater probability for the cancer to spread to other organs. But the causes of this association are still not well understood. Researchers at ...
Apr 2, 2025
0
67
Gastric cancer (GC) is a leading cause of cancer-related deaths worldwide, with more than one million new diagnoses annually. Unfortunately, many cases are detected at advanced stages due to the lack of clear early symptoms, ...
Apr 1, 2025
0
0
A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal cancers, according to ...
Apr 1, 2025
0
31
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumors in chicken eggs and analyzing their proteins.
Apr 1, 2025
0
7
The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients with previously treated advanced neuroendocrine tumors, offering a new standard of care for this ...
Mar 31, 2025
0
0
A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy.
Mar 28, 2025
0
41
Triple-negative breast cancer, an aggressive type of breast cancer, accounts for 10% of all breast cancer cases in the United States annually. CD8+ T cells that normally kill cancer cells often become exhausted and stop.
Mar 28, 2025
0
31
Helene Lindfors, Ph.D. Student at the Endocrine Surgery research group, the Department of Molecular Medicine and Surgery, will defend her thesis "Tumor burden, thyroglobulin and Ki-67 as prognostic indicators in papillary ...
Mar 27, 2025
0
0
